(Q46738149)

24 December 2017

title

Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice (English)

1 reference

24 December 2017

author

Radosveta Koldamova

series ordinal

1

1 reference

24 December 2017

Matthias Staufenbiel

series ordinal

2

object named as

Matthias Staufenbiel

1 reference

24 December 2017

author name string

Iliya Lefterov

series ordinal

3

1 reference

24 December 2017

language of work or name

English

0 references

publication date

5 October 2005

1 reference

24 December 2017

Journal of Biological Chemistry

published in

1 reference

24 December 2017

volume

280

1 reference

24 December 2017

page(s)

43224-43235

1 reference

24 December 2017

issue

52

1 reference

24 December 2017

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The current status of Alzheimer's disease genetics: what do we tell the patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Cerebral amyloid angiopathy and gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Liver X Receptor Signaling Pathways in Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Expression of Liver X Receptor Target Genes Decreases Cellular Amyloid β Peptide Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Differential expression of cholesterol hydroxylases in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The history of iron in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Risk factors for vascular dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Noninfarct vascular dementia and Alzheimer dementia spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Neurovascular mechanisms of Alzheimer's neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Serum lipids and hippocampal volume: the link to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Role of perivascular cells and myocytes in vascular amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Atherosclerosis of cerebral arteries in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Neuron loss in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

21 January 2018

Identifiers

DOI

10.1074/JBC.M504513200

1 reference

24 December 2017

PubMed ID

16207713

1 reference

24 December 2017